Literature DB >> 27671775

Cell lipid metabolism modulators 2-bromopalmitate, D609, monensin, U18666A and probucol shift discoidal HDL formation to the smaller-sized particles: implications for the mechanism of HDL assembly.

Duyen Quach1, Cecilia Vitali1, Fiona M La1, Angel X Xiao1, John S Millar1, Chongren Tang2, Daniel J Rader3, Michael C Phillips1, Nicholas N Lyssenko4.   

Abstract

ATP-binding cassette transporter A1 (ABCA1) mediates formation of disc-shaped high-density lipoprotein (HDL) from cell lipid and lipid-free apolipoprotein A-I (apo A-I). Discoidal HDL particles are heterogeneous in physicochemical characteristics for reasons that are understood incompletely. Discoidal lipoprotein particles similar in characteristics and heterogeneity to cell-formed discoidal HDL can be reconstituted from purified lipids and apo A-I by cell-free, physicochemical methods. The heterogeneity of reconstituted HDL (rHDL) is sensitive to the lipid composition of the starting lipid/apo A-I mixture. To determine whether the heterogeneity of cell-formed HDL is similarly sensitive to changes in cell lipids, we investigated four compounds that have well-established effects on cell lipid metabolism and ABCA1-mediated cell cholesterol efflux. 2-Bromopalmitate, D609, monensin and U18666A decreased formation of the larger-sized, but dramatically increased formation of the smaller-sized HDL. 2-Bromopalmitate did not appear to affect ABCA1 activity, subcellular localization or oligomerization, but induced dissolution of the cholesterol-phospholipid complexes in the plasma membrane. Arachidonic and linoleic acids shifted HDL formation to the smaller-sized species. Tangier disease mutations and inhibitors of ABCA1 activity wheat germ agglutinin and AG 490 reduced formation of both larger-sized and smaller-sized HDL. The effect of probucol was similar to the effect of 2-bromopalmitate. Taking rHDL formation as a paradigm, we propose that ABCA1 mutations and activity inhibitors reduce the amount of cell lipid available for HDL formation, and the compounds in the 2-bromopalmitate group and the polyunsaturated fatty acids change cell lipid composition from one that favors formation of the larger-sized HDL particles to one that favors formation of the smaller-sized species.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HDL heterogeneity; Inhibitors of ABCA1-mediated cholesterol efflux; Mechanism of HDL formation; Reconstituted HDL; Tangier disease mutations

Mesh:

Substances:

Year:  2016        PMID: 27671775     DOI: 10.1016/j.bbalip.2016.09.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  Is ABCA1 a lipid transfer protein?

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2018-01-05       Impact factor: 5.922

2.  Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.

Authors:  Takashi Kuwano; Xin Bi; Eleonora Cipollari; Tomoyuki Yasuda; William R Lagor; Hannah J Szapary; Junichiro Tohyama; John S Millar; Jeffrey T Billheimer; Nicholas N Lyssenko; Daniel J Rader
Journal:  J Lipid Res       Date:  2017-01-30       Impact factor: 5.922

3.  Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.

Authors:  Jens Pahnke; Pablo Bascuñana; Mirjam Brackhan; Katja Stefan; Vigneshwaran Namasivayam; Radosveta Koldamova; Jingyun Wu; Luisa Möhle; Sven Marcel Stefan
Journal:  Free Neuropathol       Date:  2021-12-13

4.  Directional ABCA1-mediated cholesterol efflux and apoB-lipoprotein secretion in the retinal pigment epithelium.

Authors:  Nicholas N Lyssenko; Naqi Haider; Antonino Picataggi; Eleonora Cipollari; Wanzhen Jiao; Michael C Phillips; Daniel J Rader; Venkata Ramana Murthy Chavali
Journal:  J Lipid Res       Date:  2018-08-03       Impact factor: 5.922

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.